Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct-Dec;8(4):298-302.
doi: 10.4103/0974-8490.188880.

Wound Healing Activity of Silibinin in Mice

Rojalini Samanta  1 , Ashok K Pattnaik  1 , Kishanta K Pradhan  1 , Beena K Mehta  1 , Shakti P Pattanayak  1 , Sugato Banerjee  1
Affiliations

Wound Healing Activity of Silibinin in Mice

Rojalini Samanta et al. Pharmacognosy Res. 2016 Oct-Dec.

Abstract

Background: Silibinin is a semi-purified fraction of silymarin contained in milk thistle (Silybum marianum Asteraceae). Primarily known for its hepatoprotective actions, silymarin may also stimulate epithelialization and reduce inflammation in excision wound. Previous studies show antioxidant, anti-inflammatory, and antimicrobial actions of silibinin. However, wound healing property of silibinin is not well studied.

Objective: This study investigates wound healing activity of silibinin topical formulation.

Materials and methods: Wound healing activity of 0.2% silibinin gel was assessed by incision and excision wound models in mice. Animals were divided into gel base, silibinin gel, and Mega Heal gel® treated groups with six animals in each group. Wound contraction, wound tissue tensile strength, and hydroxyproline content were measured, and histopathological evaluation of wound tissue of all the above treatment groups was carried out.

Results: Application of 0.2% silibinin hydrogel for 8 days led to 56.3% wound contraction compared to 64.6% using standard Mega Heal gel with a subsequent increase in hydroxyproline content, which was significantly higher (P < 0.001) over control animals showing 33.2% contraction. After 14 days, percentage of contraction reached 96.1%, 97.6%, and 86.7%, respectively. Wound tissue tensile strength with silibinin (223.55 ± 3.82 g) and standard (241.38 ± 2.49 g) was significantly higher (P < 0.001) than control (174.06 ± 5.75 g). Histopathology of silibinin and standard gel treated wound tissue showed more fibroblasts, fewer macrophage infiltration, and well-formed collagen fibers.

Conclusion: Here, we show potent wound healing activity of silibinin hydrogel formulation.

Summary: 0.2% silibinin hydrogel showed potent wound healing activity in incision and excision wound models in mice. Abbreviations Used: ROS: Reactive oxygen species.

Keywords: Excision wound; hydrogel; hydroxyproline; incision wound; silibinin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of silibinin on wound healing. Pictorial representation of wound contraction in (a) gel base-treated (b) Mega Heal gel-treated and (c) 0.2% silibinin-treated Swiss albino mice at days 0–14
Figure 2
Figure 2
Microscopic view of healing wound granulation tissue and remodeling epidermis/dermis in (a) gel base-treated (b) 0.2% silibinin-treated (c) Std (Mega Heal gel) treated (9 days) animal groups. Sections show representative images for H and E stained epidermis and dermis under × 40 objective. Arrows pointing the events of wound healing BV: Blood vessels, C: Collagen, F: Fibroblast, and M: Mononuclear cells. Scale bar represents 100 μm
Figure 3
Figure 3
Effect of silibinin on hydroxyproline content. Both 0.2% silibinin and Std (Mega Heal gel) showed a significant increase in hydroxyproline content compared to gel base-treated control animals. Each value represents mean ± standard error of mean, n = 6
None
Sugato Banerjee
See this image and copyright information in PMC

References

    1. Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75:311–35. - PMC - PubMed
    1. Kroll DJ, Shaw HS, Oberlies NH. Milk thistle nomenclature: Why it matters in cancer research and pharmacokinetic studies. Integr Cancer Ther. 2007;6:110–9. - PubMed
    1. Rainone F. Milk thistle. Am Fam Physician. 2005;72:1285–8. - PubMed
    1. Hogan FS, Krishnegowda NK, Mikhailova M, Kahlenberg MS. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer. J Surg Res. 2007;143:58–65. - PubMed
    1. Strodtbeck F. Physiology of wound healing. Nurs Rev. 2001;1:43–5.

LinkOut - more resources